Statement of Dr. Diana Zuckerman in honor of Dr. Vivian Pinn -

September 8, 2017. I am going to Charlottesville on September 13 to honor Dr. Vivian Pinn, our 2013 Foremother Awards honoree, as a major UVA medical school building is named in her honor.  Dr. Pinn received her medical degree from the University of Virginia in 1967, where she was the only African-American and only woman in her graduating class.

Statement of Dr. Zuckerman on FDA Commissioner Hamburg’s resignation -

Statement of Dr. Diana Zuckerman, President Cancer Prevention and Treatment Fund February 5, 2015 Commissioner Hamburg has been a strong voice for public health and her resignation is a major loss at a dangerous time for the FDA.  The 21st Century Cures proposed legislation represents a frightening assault on the agency and the safety of […]

The Op-Ed: FDA panels: too many conflicts or too little expertise? -

June 2013. Should FDA Advisory Committee members be allowed to have financial conflicts of interest regarding the approval of medical products? Diana Zuckerman discusses how financial ties to pharmaceutical companies can influence the voting and discussion on drug and medical device approvals, and how misunderstandings of statistics and the value of clinical trials can lead to the approval of dangerous products.

Statement of Dr. Diana Zuckerman on FDA Approval of new Silicone-Gel Breast Implant Natrelle 410 -

February 21, 2013. Yesterday the FDA quietly approved yet another questionable style of breast implants, the Natrelle 410 Highly Cohesive Anatomically Shaped Silicone-Gel Filled Breast Implant made by Allergan, Inc. Unfortunately, Allergan’s studies did not compare the safety and effectiveness of the Natrelle 410 implant to other previously approved silicone gel-filled breast implants on the market.